Case Study: a major pharma portfolio strategy group gains unbiased insight into disruptive technologies with Evaluate

Macro-Level Analysis of Global Technology R&D Trends for a Major Pharma Portfolio Strategy Group

A major pharma portfolio strategy group struggled to obtain an unbiased view of the potential impact that new and emerging technologies could have on its market. They engaged the vendor Evaluate to conduct a technology and innovation landscaping analysis to address this challenge.

Evaluate implemented a solution by formulating a customized scoring system that assessed technologies based on their competitive landscape, portfolio fit, and commercial potential. This process provided the client with a shortlist of priority technology platforms, enhancing their understanding of potentially disruptive innovations and providing critical input for a strategic company review. As a result of this analysis, Evaluate identified a forecast for global sales to grow at a 3.8% compound annual growth rate.